{"pmid":32491223,"title":"COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.","text":["COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.","Global public health is currently dealing with the explosive spread of the novel Coronavirus disease 2019 (COVID-19) [1]. This new type of viral pneumonia, spread from its first focus in Wuhan (Hubei, China) to across all the world, until a pandemic condition was declared. Clinically. the most common symptoms of the disease are cough and fever. More than 80% of patients have asymptomatic to moderate disease, but about 15% get severe pneumonia and 5% develope a multi-organ failure [2].","J Eur Acad Dermatol Venereol","Gaspari, Valeria","Neri, Iria","Misciali, Cosimo","Patrizi, Annalisa","32491223"],"abstract":["Global public health is currently dealing with the explosive spread of the novel Coronavirus disease 2019 (COVID-19) [1]. This new type of viral pneumonia, spread from its first focus in Wuhan (Hubei, China) to across all the world, until a pandemic condition was declared. Clinically. the most common symptoms of the disease are cough and fever. More than 80% of patients have asymptomatic to moderate disease, but about 15% get severe pneumonia and 5% develope a multi-organ failure [2]."],"journal":"J Eur Acad Dermatol Venereol","authors":["Gaspari, Valeria","Neri, Iria","Misciali, Cosimo","Patrizi, Annalisa"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32491223","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/jdv.16693","locations":["Wuhan","Hubei","China","Bologna","Italy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Case Report"],"weight":1,"_version_":1668892169451077635,"score":9.490897,"similar":[{"pmid":32305249,"pmcid":"PMC7159860","title":"A case of COVID-19 patient with the diarrhea as initial symptom and literature review.","text":["A case of COVID-19 patient with the diarrhea as initial symptom and literature review.","Since Dec 2019, a cluster of pneumonia outbreak in Wuhan, Hubei province, China, and soon spread to all province of China. The pathogen was proved to be a novel betacoronavirus called 2019 novel coronavirus (officially named by the World Health Organization as COVID-19). The typical clinical manifestations were fever, cough, dyspnea, and myalgia or fatigue. Less common symptoms included headache, diarrhea, nausea and vomiting. However diarrhea as the first symptom is rarely reported. Here we reported a case of 2019 novel coronavirus-infected patient (NCIP) with diarrhea as the initial symptom. Image of CT scan and laboratory examination and careful collected as well as detection of viral RNA in pharynx. The case demonstrate that gastrointestinal symptoms ware not rare in NCIP, and diarrhea could be the initial symptom.","Clin Res Hepatol Gastroenterol","Yang, Xiaodong","Zhao, Jie","Yan, Qiang","Zhang, Shangxin","Wang, Yigao","Li, Yongxiang","32305249"],"abstract":["Since Dec 2019, a cluster of pneumonia outbreak in Wuhan, Hubei province, China, and soon spread to all province of China. The pathogen was proved to be a novel betacoronavirus called 2019 novel coronavirus (officially named by the World Health Organization as COVID-19). The typical clinical manifestations were fever, cough, dyspnea, and myalgia or fatigue. Less common symptoms included headache, diarrhea, nausea and vomiting. However diarrhea as the first symptom is rarely reported. Here we reported a case of 2019 novel coronavirus-infected patient (NCIP) with diarrhea as the initial symptom. Image of CT scan and laboratory examination and careful collected as well as detection of viral RNA in pharynx. The case demonstrate that gastrointestinal symptoms ware not rare in NCIP, and diarrhea could be the initial symptom."],"journal":"Clin Res Hepatol Gastroenterol","authors":["Yang, Xiaodong","Zhao, Jie","Yan, Qiang","Zhang, Shangxin","Wang, Yigao","Li, Yongxiang"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305249","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.clinre.2020.03.013","keywords":["diarrhea","novel coronavirus"],"locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138493354508289,"score":114.84846},{"pmid":32291376,"title":"Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.","text":["Clinical Progression of COVID-19 Patient with Extended Incubation Period, Delayed RT-PCR Time-to-positivity, and Potential Role of Chest CT-scan.","Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease caused by SARS- CoV-2 which was first identified as outbreak of unknown respiratory illness in Wuhan, China. COVID- 19 was declared as global health emergency by WHO on March 11, 2020 and quickly elevated to global pandemic on 11 March 2020. COVID-19 symptom is highly various in each patient, with fever, fatigue, shortness of breath, and cough as the main presenting symptoms. Patient with COVID-19 may shows severe symptom with severe pneumonia and ARDS, mild symptom resembling simple upper respiration tract infection, or even completely asymptomatic. Approximately 80% of cases is mild. However the number may changes as more people are getting tested. Some experts are estimating that up to 50% of all cases may be asymptomatic carrier.","Acta Med Indones","Burhan, Erlina","Prasenohadi, Prasenohadi","Rogayah, Rita","Isbaniyah, Fathiyah","Reisa, Tina","Dharmawan, Ibrahim","32291376"],"abstract":["Coronavirus Disease 2019 (COVID-19), previously called 2019-nCoV, is a novel disease caused by SARS- CoV-2 which was first identified as outbreak of unknown respiratory illness in Wuhan, China. COVID- 19 was declared as global health emergency by WHO on March 11, 2020 and quickly elevated to global pandemic on 11 March 2020. COVID-19 symptom is highly various in each patient, with fever, fatigue, shortness of breath, and cough as the main presenting symptoms. Patient with COVID-19 may shows severe symptom with severe pneumonia and ARDS, mild symptom resembling simple upper respiration tract infection, or even completely asymptomatic. Approximately 80% of cases is mild. However the number may changes as more people are getting tested. Some experts are estimating that up to 50% of all cases may be asymptomatic carrier."],"journal":"Acta Med Indones","authors":["Burhan, Erlina","Prasenohadi, Prasenohadi","Rogayah, Rita","Isbaniyah, Fathiyah","Reisa, Tina","Dharmawan, Ibrahim"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291376","source":"PubMed","week":"202016|Apr 13 - Apr 19","keywords":["covid-19, sars, cov-2-"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494324441088,"score":103.41841},{"pmid":32120312,"pmcid":"PMC7125867","title":"Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease.","text":["Asymptomatic novel coronavirus pneumonia patient outside Wuhan: The value of CT images in the course of the disease.","The purpose of this case report is to describe the imaging and associated clinical features of an asymptomatic novel coronavirus pneumonia (COVID-19) patient outside Wuhan, China. The principle findings are that in this patient with laboratory-confirmed COVID-19, CT findings preceded symptoms and included bilateral pleural effusions, previously not reported in association with COVID-19. The role of this case report is promotion of potential recognition amongst radiologists of this new disease, which has been declared a global health emergency by the World Health Organization (WHO).","Clin Imaging","Lin, Chen","Ding, Yuxiao","Xie, Bin","Sun, Zhujian","Li, Xiaogang","Chen, Zixian","Niu, Meng","32120312"],"abstract":["The purpose of this case report is to describe the imaging and associated clinical features of an asymptomatic novel coronavirus pneumonia (COVID-19) patient outside Wuhan, China. The principle findings are that in this patient with laboratory-confirmed COVID-19, CT findings preceded symptoms and included bilateral pleural effusions, previously not reported in association with COVID-19. The role of this case report is promotion of potential recognition amongst radiologists of this new disease, which has been declared a global health emergency by the World Health Organization (WHO)."],"journal":"Clin Imaging","authors":["Lin, Chen","Ding, Yuxiao","Xie, Bin","Sun, Zhujian","Li, Xiaogang","Chen, Zixian","Niu, Meng"],"date":"2020-03-03T11:00:00Z","year":2020,"_id":"32120312","source":"PubMed","week":"202010|Mar 02 - Mar 08","doi":"10.1016/j.clinimag.2020.02.008","keywords":["2019-ncov","covid-19","ground glass opacities","novel coronavirus pneumonia","pleural effusion"],"locations":["Wuhan","China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138492820783104,"score":101.09148},{"pmid":32317205,"pmcid":"PMC7161490","title":"Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases.","text":["Clinical features and multidisciplinary treatment outcome of COVID-19 pneumonia: A report of three cases.","The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome.","J Formos Med Assoc","Liu, Chun","Wu, Changhui","Zheng, Xiangde","Zeng, Fanwei","Liu, Jinping","Wang, Pingxi","Zeng, Fanxin","Yuan, Lin","Zhu, Fangcheng","Gan, Xuemei","Huang, Yucheng","32317205"],"abstract":["The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic threatening global public health. In the current paper, we describe our successful treatment of three COVID-19 pneumonia patients cases including severe cases and cases with mortality risk factors. One 32-year-old male COVID-19 patient was diagnosed with severe COVID-19 pneumonia and moderate ARDS. The second COVID-19 pneumonia patient had a history of diabetes and chronic bronchitis. The third case of COVID-19 pneumonia was an 82-year old female patient. All three cases had severe COVID pneumonia and therefore were aggressively managed with a multidisciplinary and personalized therapeutic approach that included nutritional support, antiviral pharmacotherapy, active control of comorbidities, prevention of complication development and psychological intervention. Our experience highlights the importance of the use of a multidisciplinary therapeutic approach that tailors to the specific condition of the patient in achieving a favorable clinical outcome."],"journal":"J Formos Med Assoc","authors":["Liu, Chun","Wu, Changhui","Zheng, Xiangde","Zeng, Fanwei","Liu, Jinping","Wang, Pingxi","Zeng, Fanxin","Yuan, Lin","Zhu, Fangcheng","Gan, Xuemei","Huang, Yucheng"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317205","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jfma.2020.04.008","keywords":["covid-19","multidisciplinary therapeutic approach","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138493601972226,"score":100.99523},{"pmid":32455515,"title":"[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].","text":["[Clinical feature changes of a COVID-19 patient from mild to critical condition and cardiopulmonary pathological results].","Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 11, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 day post infection, and died on the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries. Steadily increased inflammation indices are suggestive of irreversible disease progression and worse outcome. In the early stages of the disease, the progress of the disease should be closely observed and evaluated, and the factors related to the progress of the disease should be identified and managed.","Zhonghua Xin Xue Guan Bing Za Zhi","Jiang, S W","Gao, H","Wu, L","Wang, G W","Cen, F L","Li, J X","Feng, C","Wen, J M","Chen, Y","He, R L","Qiao, K","Wang, Y","Liu, Y X","Wang, Z Q","32455515"],"abstract":["Objective: To analyse the clinical history, laboratory tests and pathological data of a patient who suffered from novel coronavirus pneumonia(COVID-19) and provide reference for the clinical treatment of similar cases. Methods: Data of clinical manifestation, laboratory examination, bronchoscopy, echocardiography and cardiopulmonary pathological results were retrospectively reviewed in a case of COVID-19 with rapid exacerbation from mild to critical condition. Results: This patient hospitalized at day 9 post 2019 novel coronavirus(2019-nCoV) infection, experienced progressive deterioration from mild to severe at day 11, severe to critical at day 18 and underwent extracorporeal membrane oxygenation(ECMO) and continuous renal replacement therapy(CRRT) as well as heart lung transplantation during day 28-45 day post infection, and died on the second day post heart and lung transplantation. The patient had suffered from hypertension for 8 years. At the early stage of the disease, his symptoms were mild and the inflammatory indices increased and the lymphocyte count decreased continuously. The patient's condition exacerbated rapidly with multi-organ infections, and eventually developed pulmonary hemorrhage and consolidation, pulmonary hypertension, right heart failure, malignant ventricular arrhythmias, liver dysfunction, etc. His clinical manifestations could not be improved despite viral RNAs test results became negative. The patient underwent lung and heart transplantation and finally died of multi organ failure at the second day post lung and heart transplantation. Pathological examination indicated massive mucus, dark red secretions and blood clots in bronchus. The pathological changes were mainly diffused pulmonary hemorrhagic injuries and necrosis, fibrosis, small vessel disease with cardiac edema and lymphocyte infiltration. Conclusions: The clinical course of COVID-19 can exacerbate rapidly from mild to critical with lung, liver and heart injuries. Steadily increased inflammation indices are suggestive of irreversible disease progression and worse outcome. In the early stages of the disease, the progress of the disease should be closely observed and evaluated, and the factors related to the progress of the disease should be identified and managed."],"journal":"Zhonghua Xin Xue Guan Bing Za Zhi","authors":["Jiang, S W","Gao, H","Wu, L","Wang, G W","Cen, F L","Li, J X","Feng, C","Wen, J M","Chen, Y","He, R L","Qiao, K","Wang, Y","Liu, Y X","Wang, Z Q"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32455515","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3760/cma.j.cn112148-20200304-00155","keywords":["covid-19","clinical feature","extracorporeal membrane oxygenation","heart-lung transplantation","myocardial injury"],"topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1667983494552223744,"score":100.70904}]}